📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-07-16 12:31
0 analysed today
FollowTelegram
0
Today
151,859
All-time analysed
43,535
Positive
6,743
Negative
92,744
Neutral
8,769
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
1 announcement match the current filters (relevance ≥ 5).
Kobo Biotech: Resolution Plan Implementation Delayed Beyond July 10 Deadline
Kobo Biotech Ltd has reported a failure by the Successful Resolution Applicant (SRA), Beaufond Industries Limited, to implement the NCLT-approved resolution plan within the mandated timeline. The plan, approved by the NCLT Hyderabad Bench on May 11, 2026, required completion within 60 days, which expired on July 10, 2026. A Monitoring Committee meeting is being convened to decide the next course of action, creating significant uncertainty for the company's insolvency exit. The stock has seen a speculative 365.4% rise in the last 6 months despite these ongoing insolvency proceedings.
Confidence: HIGH
What changedThe Successful Resolution Applicant missed the court-mandated 60-day deadline to implement the resolution plan for Kobo Biotech.
Why it mattersThis delay stalls the company's exit from insolvency and puts the entire turnaround process at risk, potentially leading to legal penalties for the SRA or a restart of the bidding process.
NCLT Approval Date: May 11, 2026Implementation Deadline: July 10, 2026Implementation Period: 60 days6-Month Price Return: 365.4%
📅 Short termExpect high volatility and potential downward pressure as the market digests the risk of the resolution plan falling through.
📈 Long termThe long-term viability of the company is entirely dependent on the successful implementation of an NCLT plan; failure here is a major structural setback.
⚠ Risk flags
- Default by Resolution Applicant
- Potential Liquidation Risk
- Insolvency Proceedings
- Lack of TTM Financial Data
Key Highlights
NCLT Hyderabad Bench approved the Resolution Plan on May 11, 2026.
Implementation deadline for the SRA was set for July 10, 2026 (60 days from approval).
Successful Resolution Applicant (SRA) identified as Beaufond Industries Limited.
Monitoring Committee meeting convened to deliberate on the failure to meet the deadline.
Company remains under the supervision of an Insolvency Professional as of July 14, 2026.
👀 What to Watch
Investors should monitor the outcome of the Monitoring Committee meeting to see if the SRA is granted an extension or if the resolution process faces a total breakdown, which could lead to liquidation.
